Stockreport

Allogene: Possible First Pivotal Study With Allogeneic CAR-T ALLO-501A [Seeking Alpha]

Allogene Therapeutics, Inc.  (ALLO) 
Last allogene therapeutics, inc. earnings: 2/27 04:30 am Check Earnings Report
PDF anamejia18/iStock via Getty ImagesAllogene Therapeutics, Inc.NASDAQ:ALLOallogeneic CAR-T for the treatment of patients with non- (NHL). Such a pivotal study is expected [Read more]